| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 659949 | 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone | 0.045446901295916 | 0.34392342 |
| NSC 660636 | 2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin | 0.045446901295916 | 0.21044981 |
| NSC 675000 | Null | 0.045446901295916 | 0.40249246 |
| NSC 676372 | Null | 0.045446901295916 | 0.30369947 |
| NSC 677776 | Null | 0.045446901295916 | 0.0094450132 |
| NSC 682866 | Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- | 0.0454469012959163 | 0.16748487 |
| NSC 144173 | Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- | 0.0454469012959166 | 0.1808358 |
| NSC 368697 | Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- | 0.0454469012959166 | -0.0083697905 |
| NSC 625498 | 4-Morpholinecarbodithioic acid, antimony complex | 0.0454469012959166 | 0.11954425 |
| NSC 632790 | Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) | 0.0454469012959166 | 0.23675459 |